ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase InhibitorsRyo Kimura(DIC (Japan)), Hiromichi Ebi(Aichi Cancer Center)CancersOctober 16, 202410.3390/cancers16203501Cited by 0SaveCiteExport RISWatch citationsRelated PapersPan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS|Annals of Oncology|2017|591